Allele-specific characterization of alanine: Glyoxylate aminotransferase variants associated with primary hyperoxaluria

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Lage, Melissa D ^a   Pittman, Adrianne M C ^a   Roncador, Alessandro ^b   Cellini, Barbara ^b   Tucker, Chandra L ^a,c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; ALANINE-GLYOXYLATE TRANSAMINASE; AMINOTRANSFERASE; MUTANT PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STABILITY; GENE INTERACTION; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; MISSENSE MUTATION; NONHUMAN; OXALOSIS 1; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; WILD TYPE; ALLELE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; PROTEIN MULTIMERIZATION;

ALLELES; ENZYME STABILITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPEROXALURIA, PRIMARY; MODELS, MOLECULAR; MUTANT PROTEINS; MUTATION; PROTEIN MULTIMERIZATION; TRANSAMINASES;

EID: 84899497781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094338     Document Type: Article

References (28)

1. Danpure CJ (2005) Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am J Nephrol 25: 303-310.
2. Purdue PE, Takada Y, Danpure CJ (1990) Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol 111: 2341-2351. (Pubitemid 120014519)
3. Cellini B, Lorenzetto A, Montioli R, Oppici E, Voltattorni CB (2010) Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. Biochimie 92: 1801-1811. doi:10.1016/j.biochi.2010.08.005.
4. Coulter-Mackie MB, Lian Q (2006) Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations. Mol Genet Metab 89: 349-359. (Pubitemid 44692542)
5. Coulter-Mackie MB, Lian Q, Applegarth D, Toone J (2005) The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1. Mol Genet Metab 86: 172-178. (Pubitemid 41412173)
6. Lumb MJ, Danpure CJ (2000) Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem 275: 36415-36422.
7. Hopper ED, Pittman AM, Fitzgerald MC, Tucker CL (2008) In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase. J Biol Chem 283: 30493-30502. doi:M803525200 [pii] 10.1074/jbc.M803525200.
8. Lumb MJ, Drake AF, Danpure CJ (1999) Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase. J Biol Chem 274: 20587-20596.
9. Mesa-Torres N, Fabelo-Rosa I, Riverol D, Yunta C, Albert A, et al. (2013) The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I. PLoS One 8: e71963. doi:10.1371/journal.pone.0071963.
10. Purdue PE, Allsop J, Isaya G, Rosenberg LE, Danpure CJ (1991) Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation. Proc Natl Acad Sci U S A 88: 10900-10904. (Pubitemid 21915946)
11. Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, et al. (2009) Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 30: 910-917. doi:10.1002/humu.21021.
12. Pey AL, Salido E, Sanchez-Ruiz JM (2011) Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria. Amino Acids 41: 1233-1245. doi:10.1007/s00726-010-0801-2.
13. Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, et al. (1993) Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome- tomitochondrion mistargeting and intraperoxisomal aggregation. Am J Hum Genet 53: 417-432. (Pubitemid 23308936)
14. Lumb MJ, Birdsey GM, Danpure CJ (2003) Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro. Biochem J 374: 79-87. (Pubitemid 37046931)
15. Leiper JM, Oatey PB, Danpure CJ (1996) Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome- tomitochondrion mistargeting in primary hyperoxaluria type 1. J Cell Biol 135: 939-951. (Pubitemid 26403770)
16. Pittman AM, Lage MD, Poltoratsky V, Vrana JD, Paiardini A, et al. (2012) Rapid profiling of disease alleles using a tunable reporter of protein misfolding. Genetics 192: 831-842. doi:10.1534/genetics.112.143750.
17. Cellini B, Montioli R, Paiardini A, Lorenzetto A, Maset F, et al. (2010) Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I. Proc Natl Acad Sci U S A 107: 2896-2901. doi:10.1073/pnas.0908565107.
18. Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B (2013) Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Biochim Biophys Acta 1832: 2277-2288. doi:10.1016/j.bbadis.2013.09.002.
19. Oppici E, Montioli R, Lorenzetto A, Bianconi S, Borri Voltattorni C, et al. (2012) Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. Mol Genet Metab 105: 132-140. doi:10.1016/j.ymgme.2011.09.033.
20. Cellini B, Bertoldi M, Montioli R, Paiardini A, Borri Voltattorni C (2007) Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. Biochem J 408: 39-50. doi:10.1042/BJ20070637. (Pubitemid 350158401)
21. Schlosser T, Gatgens C, Weber U, Stahmann KP (2004) Alanine: glyoxylate aminotransferase of Saccharomyces cerevisiae-encoding gene AGX1 and metabolic significance. Yeast 21: 63-73. (Pubitemid 38159256)
22. Frishberg Y, Rinat C, Shalata A, Khatib I, Feinstein S, et al. (2005) Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 25: 269-275. doi:10.1159/000086357. (Pubitemid 41202750)
23. Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, et al. (2007) Comprehensive Mutation Screening in 55 Probands with Type 1 Primary Hyperoxaluria Shows Feasibility of a Gene-Based Diagnosis. J Am Soc Nephrol 18: 1905-1914. (Pubitemid 46870327)
24. Williams E, Rumsby G (2007) Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Clin Chem 53: 1216-1221. (Pubitemid 47020976)
25. Zhang X, Roe SM, Hou Y, Bartlam M, Rao Z, et al. (2003) Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol 331: 643-652. (Pubitemid 36937151)
26. Fodor K, Wolf J, Erdmann R, Schliebs W, Wilmanns M (2012) Molecular requirements for peroxisomal targeting of alanine-glyoxylate aminotransferase as an essential determinant in primary hyperoxaluria type 1. PLoS Biol 10: e1001309. doi:10.1371/journal.pbio.1001309.
27. Robbiano A, Frecer V, Miertus J, Zadro C, Ulivi S, et al. (2010) Modeling the effect of 3 missense AGXT mutations on dimerization of the AGT enzyme in primary hyperoxaluria type 1. J Nephrol 23: 667-676.
28. Oppici E, Fodor K, Paiardini A, Williams C, Voltattorni CB, et al. (2013) Crystal structure of the S187F variant of human liver alanine: aminotransferase associated with primary hyperoxaluria type I and its functional implications. Proteins 81: 1457-1465. doi:10.1002/prot.24300.